Search - tctmd.com

Displaying 141 - 160 of 436

Sort: Relevancy | Date

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Daily News

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Shelley Wood

July 26, 2019

News Daily News

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Marcus A. Banks

July 22, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

Same-Day Discharge Safe After Elective PCI, Canadian Study Affirms

Marcus A. Banks

June 25, 2019

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Caitlin E. Cox

June 18, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Daily News

The Perils of Perusing: New Research Cautions Against Relying Solely on RCT Abstracts

Caitlin E. Cox

May 07, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

News Daily News

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

L.A. McKeown

April 15, 2019

News Daily News

Disparities Seen in Uptake of DOACs for VTE

Todd Neale

April 05, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

Advertisement

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

FDA Expands TAVR Indication to Low-Risk Patients

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Same-Day Discharge Safe After Elective PCI, Canadian Study Affirms

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

The Perils of Perusing: New Research Cautions Against Relying Solely on RCT Abstracts

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Patients Stop CVD Medications When Their Pharmacy Closes

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

Disparities Seen in Uptake of DOACs for VTE

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content